84 related articles for article (PubMed ID: 27867264)
1. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions.
Nasrin S; Watson CJW; Perez-Paramo YX; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1070-1080. PubMed ID: 34493602
[TBL] [Abstract][Full Text] [Related]
3. Studying the Inhibitory Effect of Quercetin and Thymoquinone on Human Cytochrome P450 Enzyme Activities.
Elbarbry F; Ung A; Abdelkawy K
Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S895-S899. PubMed ID: 29491651
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes.
Caggiano A; Blight A
J Drug Assess; 2013; 2(1):106-16. PubMed ID: 27536444
[TBL] [Abstract][Full Text] [Related]
5. In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.
Chen Y; Liu L; Laille E; Kumar G; Surapaneni S
Cancer Chemother Pharmacol; 2010 Apr; 65(5):995-1000. PubMed ID: 20119716
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity.
Song M; Do H; Kwon OK; Yang EJ; Bae JS; Jeong TC; Song KS; Lee S
Biomol Ther (Seoul); 2014 Feb; 22(2):155-60. PubMed ID: 24753822
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the effect of type 2 diabetes mellitus on CYP450 enzymes and P-gp activities, before and after glycemic control: A protocol for a case-control pharmacokinetic study.
Neyshaburinezhad N; Rouini M; Shirzad N; Esteghamati A; Nakhjavani M; Namazi S; Ardakani YH
MethodsX; 2020; 7():100853. PubMed ID: 32337164
[TBL] [Abstract][Full Text] [Related]
8. The roles of carboxylesterase and CYP isozymes on the in vitro metabolism of T-2 toxin.
Lin NN; Chen J; Xu B; Wei X; Guo L; Xie JW
Mil Med Res; 2015; 2():13. PubMed ID: 26140218
[TBL] [Abstract][Full Text] [Related]
9. Use of Lentivirus-Based Method for Establishing TK6 Human Cell Lines Expressing Cytochrome P450 and its Applications in Genotoxicity Testing.
Li X; Chen S; He X; Wu Q; Guo L; Mei N
Curr Protoc; 2024 Mar; 4(3):e1003. PubMed ID: 38483112
[TBL] [Abstract][Full Text] [Related]
10. Association between low body weight and cytochrome P-450 enzyme activity in patients with anorexia nervosa.
Sandvik P; Lydersen S; Hegstad S; Spigset O
Pharmacol Res Perspect; 2020 Jun; 8(3):e00615. PubMed ID: 32529756
[TBL] [Abstract][Full Text] [Related]
11. Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies.
Ramachandran SD; Vivarès A; Klieber S; Hewitt NJ; Muenst B; Heinz S; Walles H; Braspenning J
Pharmacol Res Perspect; 2015 Oct; 3(5):e00161. PubMed ID: 26516577
[TBL] [Abstract][Full Text] [Related]
12. Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism.
Ferri N; De Martin S; Stuart J; Traversa S; Folli F; Pappagallo M; O'Gorman C; Guidetti C; Mattarei A; Inturrisi CE; Manfredi PL
Drugs R D; 2024 Mar; 24(1):51-68. PubMed ID: 38010591
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family.
Lucire Y; Crotty C
Pharmgenomics Pers Med; 2011; 4():65-81. PubMed ID: 23226054
[TBL] [Abstract][Full Text] [Related]
14. Physiologically Based Pharmacokinetic Model to Assess the Influence of Blinatumomab-Mediated Cytokine Elevations on Cytochrome P450 Enzyme Activity.
Xu Y; Hijazi Y; Wolf A; Wu B; Sun YN; Zhu M
CPT Pharmacometrics Syst Pharmacol; 2015 Sep; 4(9):507-15. PubMed ID: 26451330
[TBL] [Abstract][Full Text] [Related]
15. Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.
Lapchak PA
Transl Stroke Res; 2013 Jun; 4(3):328-42. PubMed ID: 23687519
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cytochrome P450s mediated interference with glutathione and amino acid metabolisms from halogenated PAHs exposure.
Ma J; Yu H; Li G; An T
J Hazard Mater; 2024 May; 473():134589. PubMed ID: 38772114
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids and Organic Acids Affect Phase II Metabolism based on the Regulation of UGT1A1 Expression and Function.
Zhang L; Zhang X; Wang C
Curr Comput Aided Drug Des; 2024 May; ():. PubMed ID: 38766819
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram.
Jung YS; Jin BH; Choi JE; Park MS; Kim YW; Kang HW; Cho S; Kim CO
Ther Clin Risk Manag; 2024; 20():151-160. PubMed ID: 38434107
[TBL] [Abstract][Full Text] [Related]
19. Ojeok-san ameliorates visceral and somatic nociception in a mouse model of colitis induced colorectal cancer.
Cunningham P; Sumal A; Patton E; Helms H; Noneman MT; Martinez-Muñiz G; Bader JE; Chatzistamou I; Aladhami A; Unger C; Enos RT; Shin HK; Velázquez KT
PLoS One; 2022; 17(6):e0270338. PubMed ID: 35737651
[TBL] [Abstract][Full Text] [Related]
20. Complementary and Alternative Modalities (CAM) for pain management in musculoskeletal diseases (MSDs).
Bhoi D; Jain D; Garg R; Iyengar KP; Hoda W; Vaishya R; Jain VK
J Clin Orthop Trauma; 2021 Jul; 18():171-180. PubMed ID: 34017678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
